The US Food and Drug
Administration (FDA) has issued
new medication guides on its
website adding information for
Belbucal (buprenorphine) buccal
film, Invokamet (canagliflozin and
metformin hydrochloride) tablets,
Keytruda (pembrolizumab) for
injection, Letairis (ambrisentan)
tablets, Opdivo (nivolumab)
injection, Suboxone (buprenorphine
and naloxone), Sublingual Film for
sublingual or buccal administration
(CIII), Trizivir (abacavir, lamivudine,
and zidovudine) tablets and Ziagen
(abacavir) tablets.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 05 Nov 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Nov 15
